Specific inhibition of leukotriene B4 (LTB4)‐induced neutrophil emigration by 20‐hydroxy LTB4: implications for the regulation of inflammatory responses
Open Access
- 1 September 1993
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 110 (1) , 423-427
- https://doi.org/10.1111/j.1476-5381.1993.tb13827.x
Abstract
1 The interaction between leukotriene B4 (LTB4) and its metabolite, 20-hydroxy LTB4 in the control of neutrophil emigration was examined in guinea-pig skin. 2 Leukotriene B4 (10–300 ng) elicited a dose-dependent increase in neutrophil infiltration (as measured by myeloperoxidase activity) 4 h after injection into guinea-pig skin. In contrast, 20-hydroxy LTB4 (30–1000 ng) displayed only weak inflammatory activity in this assay. 3 Although 20-hydroxy LTB4 had low agonist activity, this metabolite caused a potent dose-dependent inhibition of responses to LTB4 (100 ng), when administered systemically (ED50= 1.3 μg kg−1, s.c.) without significantly affecting neutrophil infiltration in response to C5a (2 μg). Systemic administration of 20-carboxy LTB4 (10 μg) did not affect neutrophil accumulation in response to LTB4 or C5a. In addition, neither 15(S)-hydroxy 5(S)-HPETE(10 μg) nor lipoxin A4 (10 μg) inhibited responses to LTB4. 4 Addition of 20-hydroxy LTB4 (10−11–10−8 m) to human blood prior to isolation of the neutrophils led to concentration-dependent decrease in the number of LTB4 receptors and decreased chemotactic responsiveness to LTB4 without affecting responses to C5a. Incubation of blood with 20-carboxy LTB4 (10−8 m) did not reduce LTB4 receptor number of chemotactic responsivness to LTB4. 5 These data indicate that although 20-hydroxy LTB4 is a weak agonist at LTB4 receptors, it can desensitize neutrophils to the effects of LTB4 via down-regulation of the high affinity receptor and thus provides evidence for a mechanism whereby inflammatory responses may be regulated.Keywords
This publication has 44 references indexed in Scilit:
- Decreased polymorphonuclear leucocyte chemotactic response to leukotriene B4 in cystic fibrosisClinical and Experimental Immunology, 1992
- Effect of the leukotriene B4 receptor antagonist, SC-41930, on experimental allergic encephalomyelitis (EAE) in the guinea pigInflammation Research, 1991
- Omega-oxidized leukotriene B4 detected in the broncho-alveolar lavage fluid of patients with non-cardiogenic pulmonary edema, but not in those with cardiogenic edemaIntensive Care Medicine, 1991
- Binding and metabolism of leukotriene B4 by neutrophils and their subcellular organellesJournal of Cellular Physiology, 1986
- The Release of Leukotriene B4-like Material in Biologically Active Amounts from the Lesional Skin of patients with PsoriasisJournal of Investigative Dermatology, 1984
- The effects of BW755C and other anti-inflammatory drugs on eicosanoid concentrations and leukocyte accumulation in experimentally-induced acute inflammationJournal of Pharmacy and Pharmacology, 1983
- LEUKOTRIENE B4, AN INFLAMMATORY MEDIATOR IN GOUTThe Lancet, 1982
- Identification and biological activity of novel ω‐oxidized metabolites of leukotriene B4 from human leukocytesFEBS Letters, 1981
- Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response.Proceedings of the National Academy of Sciences, 1981
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980